Diana Harshbarger, R-Tenn., who last year wrote to Kennedy, asking that compounders be allowed to make certain peptides
None of GHK-Cu, BPC-157, or TB-500 has an approved human indication, and the GLOW combination specifically has no clinical trial establishing safety or efficacy in humans
5-Amino-1MQ Specifications The 5-Amino-1MQ research compound is supplied in laboratory-grade format intended for analytical and documentation-oriented use within research settings
Specific numbers from animal studies include: reported upregulation of growth hormone receptor expression in tendon fibroblasts, effects on VEGF-mediated tube formation in endothelial cell assays, and dose-dependent reductions in gastric ulcer area in rat models at doses ranging from 10 micrograms per kilogram to higher concentrations
Injection Site Reactions: Risk of infections, swelling, and pain at the injection site due to improper administration